GUMULEC, Jaromír, Michal MASAŘÍK, Vojtěch ADAM, Tomas ECKSCHLAGER, Ivo PROVAZNIK and René KIZEK. Serum and Tissue Zinc in Epithelial Malignancies: A Meta-Analysis. Plos One. San Francisco: Public library science, 2014, vol. 9, No 6, p. "e99790", 11 pp. ISSN 1932-6203. Available from: https://dx.doi.org/10.1371/journal.pone.0099790.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Serum and Tissue Zinc in Epithelial Malignancies: A Meta-Analysis
Authors GUMULEC, Jaromír (203 Czech Republic, belonging to the institution), Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution), Vojtěch ADAM (203 Czech Republic), Tomas ECKSCHLAGER (203 Czech Republic), Ivo PROVAZNIK (203 Czech Republic) and René KIZEK (203 Czech Republic).
Edition Plos One, San Francisco, Public library science, 2014, 1932-6203.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.234
RIV identification code RIV/00216224:14110/14:00080143
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1371/journal.pone.0099790
UT WoS 000338508200042
Keywords in English TRACE-ELEMENT CONCENTRATIONS; NEUTRON-ACTIVATION ANALYSIS; LUNG-CANCER PATIENTS; X-RAY-FLUORESCENCE; CU-ZN RATIO; BREAST-CANCER; HUMAN PROSTATE; COPPER/ZINC RATIO; VITAMIN-A; HEPATOCELLULAR-CARCINOMA
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 23/9/2014 14:53.
Abstract
Background and Objectives: Current studies give us inconsistent results regarding the association of neoplasms and zinc(II) serum and tissues concentrations. The results of to-date studies using meta-analysis are summarized in this paper. Methods: Web of Science (Science citation index expanded), PubMed (Medline), Embase and CENTRAL were searched. Articles were reviewed by two evaluators; quality was assessed by Newcastle-Ottawa scale; meta-analysis was performed including meta-regression and publication bias analysis. Results: Analysis was performed on 114 case control, cohort and cross-sectional studies of 22737 participants. Decreased serum zinc level was found in patients with lung (effect size = -1.04), head and neck (effect size = -1.43), breast (effect size = -0.93), liver (effect size = -2.29), stomach (effect size = -1.59), and prostate (effect size = -1.36) cancers; elevation was not proven in any tumor. More specific zinc patterns are evident at tissue level, showing increase in breast cancer tissue (effect size = 1.80) and decrease in prostatic (effect size = -3.90), liver (effect size = -8.26), lung (effect size = -3.12), and thyroid cancer (effect size = -2.84). The rest of the included tumors brought ambiguous results, both in serum and tissue zinc levels across the studies. The association between zinc level and stage or grade of tumor has not been revealed by meta-regression. Conclusion: This study provides evidence on cancer-specific tissue zinc level alteration. Although serum zinc decrease was associated with most tumors mentioned herein, further - prospective - studies are needed.
Links
NT14337, research and development projectName: Studium a charakterizace primárních nádorových buněčných linií spinocelulárních karcinomů v oblasti hlavy a krku a jejich maligní potenciál.
Investor: Ministry of Health of the CR
PrintDisplayed: 29/7/2024 21:09